Europe should change centralised procedure

29 October 2013 - Deborah Wilkes

Archived

Legislation may need to be changed if the European Union's centralised procedure is to become an attractive route to market for non-prescription medicines, according to Dr Mark Griffiths, head of regulatory EMEA at Pfizer Consumer Healthcare.

Click tags below for more information on topics:

HRA Pharma

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: